Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Anemia In Elderly Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for anemia in the elderly has seen robust expansion lately, projected to increase from $2.99 billion in 2025 to $3.26 billion in 2026, reflecting a compound annual growth rate of 9.0%. Key drivers of this historical growth encompass the increasing elderly demographic, a higher incidence of chronic ailments, the accessibility of oral iron supplements, the broadening scope of anemia care within hospital settings, and a growing recognition of nutritional shortfall issues.

The market for anemia in the elderly is projected to experience robust expansion over the upcoming years, reaching an estimated $4.59 billion by 2030 with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this forecasted growth include a heightened demand for tailored anemia treatments, a greater uptake of extended-release injectable medications, an increased emphasis on healthcare for seniors, the proliferation of anemia management in outpatient settings, and advancements in diagnostic screening within elderly care. Key developments anticipated during this forecast period involve a rise in the utilization of combination therapies, a surge in the use of injectable iron therapies, a stronger focus on the early detection of anemia in older adults, a broader availability of home-based treatment solutions, and a more significant emphasis on managing anemia associated with chronic diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

Anemia In Elderly Market Growth Factors Supporting Long-Term Expansion

The expanding demographic of older adults is anticipated to be a primary catalyst for the expansion of the anemia in the elderly market in the future. This demographic shift, characterized by a rising number and percentage of individuals aged 65 and above, is attributed to factors such as extended lifespans, reduced fertility rates, and the maturation of substantial generational cohorts. An increase in the elderly population consequently elevates the incidence of both age-specific ailments and persistent health issues, which are recognized as substantial contributors to anemia among seniors. This heightened prevalence consequently boosts the demand for diagnostic tools, therapeutic interventions, and ongoing care for anemia, thereby stimulating market expansion. As an illustration, data from January 2024, as reported by the Population Reference Bureau, indicates that the segment of the U.S. population aged 65 or older is projected to increase from 58 million in 2022 to 82 million by the year 2050, representing a significant growth of 47%. Concurrently, this age cohort’s proportion within the total population is forecast to climb from 17% to 23% over the identical timeframe, underscoring the substantial influence of the aging population on the anemia in elderly market’s growth trajectory.

Anemia In Elderly Market Segment Analysis: What Are The Major Market Categories?

The anemia in elderly market covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

Anemia In Elderly Market Industry Trends Shaping Future Revenue Growth

Within the anemia in the elderly market, leading enterprises are directing their efforts toward embracing innovation, particularly in the realm of tailored treatments, aiming to optimize therapeutic pathways, elevate patient results, minimize adverse reactions, and boost the overall effectiveness of healthcare delivery. Personalized therapies signify medical interventions specifically designed around a patient’s unique attributes. As an illustration of this, in March of 2024, a pharmaceutical firm headquartered in India, Cadila Pharmaceuticals, revealed the introduction of Redshot FCM, a groundbreaking iron injection formulated to address iron deficiency anemia in individuals who cannot tolerate oral iron supplements; this intravenous iron solution provides sufficient iron levels while boasting an excellent safety record, and its innovative Ferric Carboxymaltose composition enhances both the delivery and absorption of iron, thereby underscoring Cadila Pharmaceuticals’ commitment to advancing healthcare through the creation of individualized treatment approaches that cater to specific patient circumstances, ultimately yielding superior outcomes for iron deficiency anemia.

Anemia In Elderly Market Leading Companies Driving Competitive Growth

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Access The Complete Anemia In Elderly Market Report:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Anemia In Elderly Market Largest Region By Revenue And Market Share

North Americawas the largest region in the anemia in elderly market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model